Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-21 20:26:46 UTC |
---|
Update Date | 2014-12-24 20:25:51 UTC |
---|
Accession Number | T3D2773 |
---|
Identification |
---|
Common Name | Procyclidine |
---|
Class | Small Molecule |
---|
Description | Procyclidine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. The mechanism of action is unknown. It is thought that Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia. Many of its effects are due to its pharmacologic similarities with atropine. Procyclidine exerts an antispasmodic effect on smooth muscle, and may produce mydriasis and reduction in salivation. |
---|
Compound Type | - Amine
- Antidyskinetic
- Antiparkinson Agent
- Drug
- Metabolite
- Muscarinic Antagonist
- Organic Compound
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | 1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride | 1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol | Arpicolin | Extranil | Kdrine | Kemadren | Kemadrin | Osnervan | Prociclidina | Procyclidin | Procyclidinum | Prodine | Proimer | Tricyclamol |
|
---|
Chemical Formula | C19H29NO |
---|
Average Molecular Mass | 287.440 g/mol |
---|
Monoisotopic Mass | 287.225 g/mol |
---|
CAS Registry Number | 77-37-2 |
---|
IUPAC Name | 1-cyclohexyl-1-phenyl-3-(pyrrolidin-1-yl)propan-1-ol |
---|
Traditional Name | procyclidine |
---|
SMILES | OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2 |
---|
InChI Key | InChIKey=WYDUSKDSKCASEF-UHFFFAOYNA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | Aralkylamines |
---|
Alternative Parents | |
---|
Substituents | - Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- N-alkylpyrrolidine
- 1,3-aminoalcohol
- Pyrrolidine
- Tertiary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Organopnictogen compound
- Alcohol
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 86°C | Boiling Point | Not Available | Solubility | Moderately soluble in water, ~ 30 mg/ml | LogP | 4.2 |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-053r-9510000000-bb5c957fcb63641b16df | 2017-09-01 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-00c3-9371000000-a8f31f6dd1ab688edc1c | 2017-10-06 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00dr-0090000000-346bcbb2ab2d7175b1bc | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-9240000000-b149734e30140564cb67 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a4l-9210000000-752d38a1eb305bdc9d05 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-15b4d4f82fafa22bb285 | 2016-08-04 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0079-9080000000-bcb7857676f4ed8009ed | 2016-08-04 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00di-9010000000-1fd43c480f58b0322708 | 2016-08-04 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-000i-0090000000-2c6fa3370147096c5f4a | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-9020000000-24b280b9f79606f08243 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001r-9410000000-06aeaae65e74e5546cf4 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-8ae387832bf542033b12 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-000i-1490000000-6ae75c02122c9e6e0e04 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-001i-0490000000-f468d30ac48d7ded8da4 | 2021-09-24 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-001i-9010000000-7d7f1b16f54aaca37f10 | 2014-09-20 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral |
---|
Mechanism of Toxicity | The mechanism of action is unknown. It is thought that Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia. Many of its effects are due to its pharmacologic similarities with atropine. Procyclidine exerts an antispasmodic effect on smooth muscle, and may produce mydriasis and reduction in salivation. |
---|
Metabolism | Not Available |
---|
Toxicity Values | LD50=60 mg/kg (IV in mice) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | LD50=60 mg/kg (IV in mice) |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00387 |
---|
HMDB ID | HMDB14531 |
---|
PubChem Compound ID | 4919 |
---|
ChEMBL ID | CHEMBL86715 |
---|
ChemSpider ID | 4750 |
---|
KEGG ID | C07378 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 8448 |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Procyclidine |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Procyclidine |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D2773.pdf |
---|
General References | - Theodoridis GC, Stark L: Central role of solar information flow in pregenetic evolution. J Theor Biol. 1971 Jun;31(3):377-88. [5556140 ]
- Drugs.com [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|